APRIL 4, 2019:

NANOBIOTIX ANNOUNCES FIRST EVER RADIOENHANCER

TO RECEIVE EUROPEAN MARKET APPROVAL

NANOMEDICINE

FOR BETTER AND LONGER LIFE

Watch our

R&D Day

Experts

Dr. David Raben, MD University of Colorado, Denver, CO, USADr. Tanguy Seiwert, MD University of Chicago Medicine, Chicago, IL, USADr. Colette Shen, MD, PhD University of North Carolina, Chapel Hill, NC, USADr. Jared Weiss, MD University of North Carolina, Chapel Hill, NC, USADr. James Welsh, MD MD Anderson Cancer Center, Houston, TX, USA

NANOXRAY

A FIRST-IN-CLASS RADIOENHANCER

A FIRST-IN-CLASSRADIOENHANCER

WE WORK TO PROVIDE

INNOVATIVE TREATMENTS TO HELP PATIENTS

TO LIVE LONGER AND BETTER.

COLETTE, CLINICAL TEAM

I WORK FOR LIFE.

CLINE, DISCOVERY TEAM

WE FIGHT FOR

MEANINGFUL GOALS TOGETHER.

ALY, FINANCE TEAM

NANOMEDICINE IS MORE THAN EVOLUTION,

ITS A REVOLUTION!

REGIS, MANUFACTURING AND SUPPLY TEAM

ENTHUSIASM,

FAITH IN NANOMEDICINE

AND LOVE FOR INNOVATION!

JULIE, DISCOVERY TEAM

NANOMEDICINEFOR BETTER AND LONGER LIFE

Nanobiotix announces first ever radioenhancerto receive European market approval

MEET US AT:Frontiers in Cancer Immunotherapy, New York

QUICK SELECT OR SCROLL DOWN

See more here:

Nanobiotix a nanomedicine company